Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,303 INR | +0.70% | +0.95% | -3.89% |
May. 24 | Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution | MT |
May. 16 | Caplin Point Laboratories to Seek Acquisitions | CI |
Sales 2024 | 16.94B 203M | Sales 2025 * | 19.67B 236M | Capitalization | 98.3B 1.18B |
---|---|---|---|---|---|
Net income 2024 | 4.57B 54.78M | Net income 2025 * | 5.23B 62.63M | EV / Sales 2024 | 5.91 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5 x |
P/E ratio 2024 |
22
x | P/E ratio 2025 * |
18.8
x | Employees | 1,642 |
Yield 2024 * |
0.24% | Yield 2025 * |
0.25% | Free-Float | 25.34% |
Latest transcript on Caplin Point Laboratories Limited
1 day | +1.55% | ||
1 week | +1.80% | ||
Current month | +1.93% | ||
1 month | +0.27% | ||
3 months | -4.26% | ||
6 months | +9.05% | ||
Current year | -3.07% |
Managers | Title | Age | Since |
---|---|---|---|
Sridhar Ganesan
CEO | Chief Executive Officer | 69 | 15-03-27 |
D. Muralidharan
DFI | Director of Finance/CFO | - | 16-02-18 |
Anto V.
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | - | |
Chief Operating Officer | - | 10-11-30 | |
Sridhar Ganesan
CEO | Chief Executive Officer | 69 | 15-03-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 112 M€ | +5.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 1,303 | +0.70% | 7 699 |
24-06-05 | 1,294 | +4.32% | 16,358 |
24-06-04 | 1,241 | -3.85% | 25,428 |
24-06-03 | 1,290 | +0.07% | 4,973 |
24-05-31 | 1,290 | -0.12% | 2,247 |
Delayed Quote Bombay S.E., June 06, 2024 at 04:04 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.07% | 1.18B | |
+15.96% | 42.79B | |
+22.20% | 22.81B | |
+15.89% | 15.04B | |
+17.95% | 14.49B | |
+51.29% | 12.65B | |
-11.45% | 6.74B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.55% | 5.47B |
- Stock Market
- Equities
- CAPLIPOINT Stock